Myonex Acquires SaveWay Compounding Pharmacy

April 10, 2024

Myonex has completed the acquisition of SaveWay Compounding Pharmacy, a Newark, Delaware-based compounding pharmacy, to expand its direct-to-patient and home healthcare capabilities for clinical trials across the United States. The purchase enhances Myonex's clinical trial supply offerings—adding compounding, drug sourcing and dispensing capabilities to support decentralized and hybrid trials nationwide.

Buyers
Myonex
Targets
SaveWay Compounding Pharmacy
Location
Delaware, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.